Market outlook to 2032: future trends across the seven major markets
European Pharmaceutical Review
JANUARY 18, 2024
Comparatively, in 2015, GlobalData’s research expected that sales of therapies for Gaucher disease will reach $1.16 GlobalData anticipated it will launch in the US and 5EU (France, Germany, Italy, Spain, and the UK) markets during the forecast period, Sulayman Patel, MSci, Pharma Analyst at GlobalData noted. “As billion by 2024.
Let's personalize your content